Search
Add filters:
Use filters to refine the search results.
Results 1-6 of 6 (Search time: 0.104 seconds).
- previous
- 1
- next
Item hits:
Issue Date | Title | Author(s) |
---|---|---|
18-Jul-2012 | Quality of life and adverse effects of olanzapine versus risperidone therapy in patients with schizophrenia | Araújo, Aurigena Antunes de; Chaves, Katarina Melo; Serrano-Blanco, Antoni; Ribeiro, Susana Barbosa; Soares, Luiz Alberto Lira; Guerra, Gerlane Coelho Bernardo; Alves, Maria do Socorro Costa Feitosa; Araújo Júnior, Raimundo Fernandes de; Rachetti, Vanessa de Paula Soares; Filgueira Júnior, Antônio |
Jun-2016 | Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users | Araújo, Aurigena Antunes de; Ribeiro, Susana Barbosa; Santos, Ana Cely Souza dos; Lemos, Telma Maria Araújo Moura; Medeiros, Caroline Addison Xavier; Guerra, Gerlane Coelho Bernardo; Araújo Júnior, Raimundo Fernandes de; Serrano-Blanco, Antoni; Rubio-Valera, Maria |
1-May-2014 | Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs | Araújo, Aurigena Antunes de; Dantas, Diego de Araújo; Nascimento, Gemma Galgani do; Ribeiro, Susana Barbosa; Chaves, Katarina Melo; Silva, Vanessa de Lima; Araújo Jr., Raimundo Fernandes de; Souza, Dyego Leandro Bezerra de; Medeiros, Caroline Addison Carvalho Xavier de |
26-Nov-2016 | Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics | Araújo, Aurigena Antunes de; Ribeiro, Susana Barbosa; Medeiros, Caroline Addison Xavier; Chaves, Katarina Melo; Alves, Maria do Socorro Costa Feitosa; Oliveira, Antonio Gouveia; Martins, Rand Randall |
Sep-2011 | Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia | Soares, Bruno Lobão; Oliveira, João Paulo Maia de; Machado-de-Sousa, João Paulo; Baker, Glen B.; Dursun, Serdar; Hallak, Jaime E. C. |
Mar-2015 | Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week | Maia-de-Oliveira, Joao Paulo; Soares, Bruno Lobão; Ramalho, Thais; Gavioli, Elaine C.; Soares, Vanessa Paula; Teixeira, Leslie; Baker, Glen B.; Dursun, Serdar M.; Hallak, Jaime E.C. |
Discover
Subject